Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:30:24 EDT Sun 05 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:LNTH
- LANTHEUS HOLDINGS INC -
Website unknown - click to update
12:30:24 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
LNTH
- Q
8.0
75.45
·
78.00
0.5
75.53
-2.65
-3.4
1,837.9
135,430
22,415
78.00
79.97
74.95
100.8505 50.20
19:59:00
May 02
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 22415
More trades...
Time ET
Ex
Price
Change
Volume
19:59:00
Q
75.756
-2.424
1
19:25:52
Q
75.45
-2.73
1
19:05:39
Q
75.98
-2.20
30
18:59:47
Q
75.99
-2.19
2
18:30:45
Q
75.70
-2.48
50
18:27:09
Q
75.70
-2.48
19
18:01:48
Q
75.99
-2.19
50
17:56:23
Q
74.40
-3.78
1,456
17:25:43
Q
75.99
-2.19
15
17:09:13
Q
74.00
-4.18
2
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-02 07:00
U:LNTH
News Release
200
Lantheus Reports First Quarter 2024 Financial Results
2024-04-18 08:00
U:LNTH
News Release
200
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
2024-03-05 08:30
U:LNTH
News Release
200
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
2024-03-04 08:30
U:LNTH
News Release
200
Lantheus Announces the FDA Approval of DEFINITY(TM) (Perflutren Lipid Microsphere) for Pediatric Patients
2024-02-28 08:30
U:LNTH
News Release
200
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
2024-02-26 08:30
U:LNTH
News Release
200
Lantheus to Present at the TD Cowen 44th Annual Health Care Conference
2024-02-22 07:00
U:LNTH
News Release
200
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-13 08:30
U:LNTH
News Release
200
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
2024-02-08 08:00
U:LNTH
News Release
200
Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
2024-01-23 07:45
U:LNTH
News Release
200
Lantheus Announces CEO Succession Plan
2024-01-11 08:00
U:LNTH
News Release
200
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA ‚ ® (Lutetium Lu 177 Dotatate)
2024-01-09 08:00
U:LNTH
News Release
200
Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics
2024-01-09 07:55
U:LNTH
News Release
200
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
2024-01-03 08:30
U:LNTH
News Release
200
Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-18 07:30
U:LNTH
News Release
200
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
2023-11-08 08:00
U:LNTH
News Release
200
Lantheus to Present at the Jefferies London Healthcare Conference
2023-11-02 07:00
U:LNTH
News Release
200
Lantheus Reports Third Quarter 2023 Financial Results
2023-10-19 08:00
U:LNTH
News Release
200
Lantheus to Host Third Quarter 2023 Earnings Conference Call and Webcast on ‚ November 2, 2023, at 8:00 a.m. Eastern Time
2023-09-01 08:30
U:LNTH
News Release
200
Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI ¢ „ ¢ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting
2023-08-31 08:00
U:LNTH
News Release
200
Lantheus to Present at the Wells Fargo Healthcare Conference